Results 301 to 310 of about 191,747 (328)
Some of the next articles are maybe not open access.
The overprediction of fear and panic in panic disorder
Behaviour Research and Therapy, 1994The present study examined changes in the prediction of fear and panic in a clinical sample of patients (N = 25) meeting DSM-III-R criteria for panic disorder with agoraphobia (PDA). Data were collected for approx. 2000 trials of in vivo exposure. As expected, PDA patients displayed a bias for overpredicting both the level of fear and the likelihood of
Kristine M. Jacquin +2 more
openaire +3 more sources
Panic and panic disorder in the United States
American Journal of Psychiatry, 1994The goal of this study was to determine the prevalence of DSM-III-R panic disorder and to describe its correlates.The study was part of the National Comorbidity Survey, the first psychiatric epidemiologic survey of the entire U.S. population and the first to use DSM-III-R criteria for diagnosis.
Ronald C. Kessler +3 more
openaire +3 more sources
Journal of Clinical Psychopharmacology, 1990
Twenty-five patients with a primary DSM-III-R diagnosis of panic disorder with or without agoraphobia were treated openly with the serotonin uptake inhibitor fluoxetine for up to 12 months. For most patients, treatment was initiated at 5 mg/day to minimize adverse effects previously reported with initiation at higher doses.
Eric Hollander +6 more
openaire +2 more sources
Twenty-five patients with a primary DSM-III-R diagnosis of panic disorder with or without agoraphobia were treated openly with the serotonin uptake inhibitor fluoxetine for up to 12 months. For most patients, treatment was initiated at 5 mg/day to minimize adverse effects previously reported with initiation at higher doses.
Eric Hollander +6 more
openaire +2 more sources
The genetics of panic disorder
Current Psychiatry Reports, 2001Of the anxiety disorders, panic disorder (PD) has been the most extensively studied from a genetic standpoint. Results of family studies have consistently demonstrated that PD runs in families, and twin studies indicate that genes contribute to this familiality.
Jordan W. Smoller, Christine T. Finn
openaire +3 more sources
Psychopathology of panic attacks in panic disorder
Journal of Affective Disorders, 2006This study examined the relationships among certain subtypes of panic attacks (full vs. limited symptom; spontaneous vs. situational) and between these subtypes, panic disorder subtypes, and other characteristics of panic disorder, especially agoraphobia.Data were drawn from a large (n = 1,168) treatment study of panic disorder in which panic attacks ...
William Matuzas +2 more
openaire +3 more sources
2004
Publisher Summary The chapter focuses on sympathetic nervous activity and epinephrine secretion rates and epinephrine cotransmission in sympathetic nerves. Multiunit sympathetic nerve firing rates measured directly by microneurography, in the sympathetic outflow to the skeletal muscle vasculature, and rates of norepinephrine spillover from the ...
Margaret J. Morris +8 more
openaire +3 more sources
Publisher Summary The chapter focuses on sympathetic nervous activity and epinephrine secretion rates and epinephrine cotransmission in sympathetic nerves. Multiunit sympathetic nerve firing rates measured directly by microneurography, in the sympathetic outflow to the skeletal muscle vasculature, and rates of norepinephrine spillover from the ...
Margaret J. Morris +8 more
openaire +3 more sources
The Canadian Journal of Psychiatry, 1991
This paper presents the cases of two patients who suffered from panic disorder with agoraphobia and depression. One had been refractory to alprazolam and tricyclics and to behaviour therapy; she had responded to phenelzine, but due to a weight gain of 50 lbs, had discontinued treatment and she relapsed.
Leslie Solyom, B. Ledwidge, Carol Solyom
openaire +3 more sources
This paper presents the cases of two patients who suffered from panic disorder with agoraphobia and depression. One had been refractory to alprazolam and tricyclics and to behaviour therapy; she had responded to phenelzine, but due to a weight gain of 50 lbs, had discontinued treatment and she relapsed.
Leslie Solyom, B. Ledwidge, Carol Solyom
openaire +3 more sources
Epidemiology of Panic Disorder
Human Psychopharmacology: Clinical and Experimental, 1997The prevalence of panic disorder in the general population is 2,3% over a person's whole life, and 0,5-1% per year. International studies have yielded more widely varying estimates of the prevalence of panic attacks (4-12%). The proportion of patients consulting their doctors for panic disorder is also highly variable; the frequency is a function of ...
openaire +3 more sources
Panic Disorder and Agoraphobia
1996Panic disorder and agoraphobia are among the most frequent referrals in mental health care. The treatment of agoraphobia has received considerable attention from the early days of behavior therapy onward. As of the early 1980s, diagnostic and theoretical refinements led to an increased emphasis on the occurrence and treatment of panic attacks.
Bouman, T.K., Emmelkamp, P.M.G.
openaire +4 more sources
Cholecystokinin and panic disorder
Acta Neuropsychiatrica, 2004Evidence for implication of cholecystokinin (CCK) in the neurobiology of panic disorder is reviewed through animal and human pharmacological studies. The results of these investigations raise two issues: (i) selectivity of action of CCK-2 agonists in anxiety disorders; and (ii) aberrations of the CCK system in anxiety disorders, both of which are ...
Michel Bourin, Eric Dailly
openaire +3 more sources